LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p

Min Xiong1, Quanjun Yang1, Le Cheng1

  • 1Department of Oncology, Affiliated Renhe Hospital of China Three Gorges University, Yichang, Hubei, 443000, People's Republic of China.

Abstract

Insights

Long non-coding RNA LINC01128 is highly expressed in triple-negative breast cancer (TNBC) and promotes tumor progression by suppressing miR-32-5p. This suggests LINC01128 is a potential therapeutic target for TNBC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
  • Long non-coding RNAs (lncRNAs) play crucial roles in cancer development and progression.
  • Understanding the molecular mechanisms underlying TNBC is essential for developing novel treatments.

Purpose of the Study:

  • To investigate the expression and clinical significance of LINC01128 in TNBC.
  • To determine if LINC01128 regulates TNBC cell behaviors by targeting miR-32-5p through the competing endogenous RNA (ceRNA) mechanism.
  • To explore LINC01128 as a potential therapeutic target for TNBC.

Main Methods:

  • Quantitative real-time PCR (qPCR) to measure LINC01128 and miR-32-5p expression in TNBC tissues and cell lines.
  • Dual-luciferase reporter assay to confirm the direct binding between LINC01128 and miR-32-5p.
  • Cell proliferation, apoptosis, and migration assays (CCK-8, flow cytometry, Transwell) to assess the functional impact of LINC01128.
  • Bioinformatic analyses (miRDB, miRWalk) for target gene prediction and pathway enrichment.

Main Results:

  • LINC01128 was significantly upregulated in TNBC tissues and cells compared to normal controls.
  • High LINC01128 expression correlated with advanced TNBC and served as an independent risk factor.
  • miR-32-5p was downregulated in TNBC and showed a negative correlation with LINC01128.
  • LINC01128 promoted TNBC cell proliferation and migration while inhibiting apoptosis by sponging miR-32-5p.
  • Target genes of miR-32-5p were enriched in cancer-related pathways.

Conclusions:

  • LINC01128 is highly expressed in TNBC and drives tumor progression.
  • The LINC01128/miR-32-5p ceRNA axis plays a critical role in regulating TNBC cell behaviors.
  • LINC01128 represents a promising molecular marker and therapeutic target for TNBC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K